WBA
34
7
CHK
7
-5
F
47
3
LRCX
83
2
EXC
40
5
AZO
52
2
CMA
36
2
CCL
46
3
SCHW
48
2
COF
62
2
SBUX
35
-2
WHR
53
-5
OKE
62
6
PFE
23
2
HRB
83
3
T
39
3
GME
62
2
ESS
79
2
INTC
44
-9
HAS
46
-2
WBA
34
7
CHK
7
-5
F
47
3
LRCX
83
2
EXC
40
5
AZO
52
2
CMA
36
2
CCL
46
3
SCHW
48
2
COF
62
2
SBUX
35
-2
WHR
53
-5
OKE
62
6
PFE
23
2
HRB
83
3
T
39
3
GME
62
2
ESS
79
2
INTC
44
-9
HAS
46
-2
Financhill
Back

Lennar Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
48

LEN
Lennar

Last Price:
148.72
Seasonality Move:
4.8%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
37.44
Seasonality Move:
3.65%
Sell
48
Lennar (LEN) is a Sell

Is Lennar a Buy, Sell or Hold?

  • The current Lennar [LEN] share price is $148.72. The Score for LEN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • LEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LEN Stock Price Chart

What is Lennar's stock price today?

  • The Lennar share price today is $148.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEN is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

LEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.6 Sell
Relative Strength Index (14 RSI): 37.62 Sell
Chaikin Money Flow: -4455236 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (153.15 - 162.83) Sell
Bollinger Bands (100): (152.31 - 163.35) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 37.74 Sell
Chaikin Money Flow: -836354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.26 - 42.36) Sell
Bollinger Bands (100): (41.26 - 48.86) Sell

LEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 154.01 Sell
20-day SMA: 156.09 Sell
50-day SMA: 157.25 Sell
200-day SMA: 142.39 Buy
8-day EMA: 154.1 Sell
20-day EMA: 156.01 Sell
50-day EMA: 157.21 Sell
200-day EMA: 145.13 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.11 Sell
20-day SMA: 40.61 Sell
50-day SMA: 42.43 Sell
200-day SMA: 42.45 Sell
8-day EMA: 40.32 Sell
20-day EMA: 40.92 Sell
50-day EMA: 42.29 Sell
200-day EMA: 43.55 Sell

Lennar Earnings Growth & LEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.89 per share, an increase this year of $0.49 per share, and an increase next year of $2.23 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

Lennar Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):